Uteron Pharma : Research for woman future Uteron Pharma : Research for woman future Uteron Pharma : Research for woman future
Uteron Pharma : Research for woman future

2013/01/23 : Watson Acquires Uteron Pharma

Read more


2012/05/2 : Uteron Pharma is contemplating a public offering to finance the (...)

Read more


2012/04/24 : Professor Jean-Michel Foidart has been awarded the Bologne-Lemaire (...)

Read more



Uteron Pharma : Research for woman future

Latest news

January 23 2013 : Watson Acquires Uteron Pharma

Parsippany, January 23, 2013 – Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that it has completed the acquisition of Belgium-based Uteron Pharma SA for $150 million in cash up front, and up to $155 million in potential future milestone (...)




May 2 2012 : Uteron Pharma is contemplating a public offering to finance the development of its product portfolio

Following the successful completion of a 14 million EUR capital raise in April 2012, Uteron Pharma continues to evaluate its options for future funding of its product portfolio. A public offering is being considered.




April 24 2012 : Professor Jean-Michel Foidart has been awarded the Bologne-Lemaire Prize!




March 30 2012 : Uteron Pharma successfully raises 14 million EUR

Liege, March 28 2012 – Uteron Pharma successfully completed a 14 million EUR capital increase. This new equity round enables Uteron Pharma to further finance its strong growth ambitions as a specialist in female healthcare.




January 4 2012 : Uteron participated in the Belgian Economic Mission to Chile

Uteron, represented by François Fornieri (CEO), participated to the economic mission led by HRH Prince Philippe in Chile from 3th to 7th December 2011. This mission has focused primarily on the capital, Santiago.




January 1 2012 : Uteron wishes you a Happy New Year 2012 !

Happy New Year 2012 !




October 31 2011 : Uteron participated in the Economic Mission to China

Uteron, represented by François Fornieri (CEO), participated to the mission led by HRH Prince Philippe in the Republic of China from 20 to 29 October 2011 as part of the cooperation agreement between federal authority and Regions. Several areas were targeted during this mission such as Life (...)




September 13 2011 : The SRIW increases its shareholding in Uteron Pharma

With an additional investment of €1,5 million, the Walloon investment company SRIW confirms its confidence in the growth potential of Uteron Pharma, a dedicated female healthcare company located in Liège.




May 4 2011 : Uteron Pharma successfully closes 7 mio EUR capital increase

The newly issued capital shall enable Uteron Pharma to further finance its strong growth ambitions as a specialist in female healthcare.







© 2011 Uteron Pharma - Legal - Privacy policy Designed and Powered by Lusis Communication

Company

Background
History
Location
Contact us

Products

Levosert™
Diafert™

Production

Market

Newsroom

Uteron Pharma : Research for woman future